Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatr Surg ; 31(6): 747-9, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8783091

ABSTRACT

Nonspecific abdominal pain is a significant problem in the pediatric population, and there has been much recent interest in the role that Helicobacter pylori (HP) might play in this disorder. A retrospective review was conducted at our center to determine its prevalence among children with otherwise undiagnosed abdominal pain. The study was conducted over a 45-month period during which 47 patients underwent gastroscopy and antral biopsies in the workup of this problem. Of the 37 patients who did not have a history of acid-pepsin disease (APD), only one (2.7%) tested positive for HP. In contrast, of the 10 who had a history of APD, three (30%) tested positive (P < .03). There were no distinguishing features among the HP-positive patients except for the presence of associated antral gastritis. Based on the current endoscopic results, of the nine patients with current evidence of APD, four (44%) were positive for HP; of the other 38 patients, none was positive for HP. Therefore, HP appears to be associated with antral gastritis, and HP does not play a role in nonspecific abdominal pain in this population.


Subject(s)
Abdominal Pain/microbiology , Helicobacter Infections/complications , Helicobacter pylori , Adolescent , Child , Female , Gastritis/diagnosis , Gastritis/microbiology , Gastroscopy , Helicobacter Infections/diagnosis , Humans , Male , Pyloric Antrum/pathology , Recurrence , Retrospective Studies
2.
J Pediatr Surg ; 31(6): 791-3, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8783105

ABSTRACT

Surgical access for nutrition is required in a variety of pediatric disorders. In some, the presence of gastroesophageal reflux, poor gastric emptying, and risks for fundoplication favor the use of a jejunostomy. The significant problems associated with the simple loop jejunostomy can be avoided by using the Roux-en-Y configuration. The stoma can be fashioned either Brook-style (intubatable) or Stamm-style (modified Maydl, permanently intubated). Both types are used at the authors' institution and are compared in this retrospective review. During a 27-month period, 22 Roux-en-Y jejunostomies were performed; nine of them had the Brook-style stoma and 13 had the modified Maydl stoma. Significant complications requiring reoperation occurred in three (33%) patients with a Brook-style jejunostomy: prolapse, leakage, and perforation of the stoma. None of the patients with modified Maydl jejunostomies required reoperation; problems were encountered more with the care of the permanently intubated stoma. Therefore, our preferred choice for a feeding jejunostomy is the modified Maydl approach.


Subject(s)
Anastomosis, Roux-en-Y/methods , Intubation, Gastrointestinal/instrumentation , Jejunostomy/methods , Adolescent , Anastomosis, Roux-en-Y/adverse effects , Catheters, Indwelling , Child , Child, Preschool , Female , Humans , Infant , Intubation, Gastrointestinal/adverse effects , Jejunostomy/adverse effects , Male , Retrospective Studies , Silicone Elastomers
3.
Br J Pharmacol ; 102(1): 13-8, 1991 Jan.
Article in English | MEDLINE | ID: mdl-2043919

ABSTRACT

1. Rats were used to evaluate the antiarrhythmic properties of tedisamil, a novel agent with the electrophysiological properties of a Class III antiarrhythmic drug. Tedisamil was tested against coronary artery occlusion-induced arrhythmias in conscious animals. 2. The actions of tedisamil on the ECG, as well as responses to electrical stimulation, were compared with those on the configuration of epicardial intracellular action potentials recorded in vivo. 3. Tedisamil (1-4 mg kg-1, i.v.) caused bradycardia, elevated blood pressure and dose-dependently reduced ventricular fibrillation (VF) induced by occlusion of the left anterior descending coronary artery. Other ischaemia-associated arrhythmias were not so well suppressed. Antiarrhythmic activity was greatest when the tedisamil-induced bradycardia was prevented by electrically-pacing the left ventricle. 4. Tedisamil dose-dependently lengthened the effective refractory period and prevented electrically-induced VF. In vivo, tedisamil (0.5-4 mg kg-1, i.v.) prolonged the duration of epicardial intracellular action potentials by up to 400%. 5. Results showed that tedisamil possessed antifibrillatory actions in rats that were related to Class III electrophysiological actions as revealed by electrical stimulation and electrophysiological analyses.


Subject(s)
Anti-Arrhythmia Agents , Bridged Bicyclo Compounds, Heterocyclic , Bridged Bicyclo Compounds/pharmacology , Cyclopropanes/pharmacology , Potassium Channels/drug effects , Action Potentials/drug effects , Animals , Arterial Occlusive Diseases/physiopathology , Blood Pressure/drug effects , Coronary Disease/physiopathology , Dose-Response Relationship, Drug , Electric Stimulation , Electrocardiography , Heart/drug effects , Heart Rate/drug effects , Male , Myocardial Infarction/physiopathology , Rats , Rats, Inbred Strains , Refractory Period, Electrophysiological/drug effects , Ventricular Fibrillation/drug therapy , Ventricular Fibrillation/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...